| Primary |
| Neuromuscular Blockade |
23.6% |
| Product Used For Unknown Indication |
21.8% |
| Anaesthesia |
5.5% |
| Surgery |
5.5% |
| Intubation |
4.5% |
| Blood Glucose Abnormal |
3.6% |
| Cardiac Arrest |
3.6% |
| Pyrexia |
3.6% |
| Therapeutic Hypothermia |
3.6% |
| Drug Use For Unknown Indication |
2.7% |
| Endotracheal Intubation |
2.7% |
| Induction Of Anaesthesia |
2.7% |
| Muscle Relaxant Therapy |
2.7% |
| Paralysis |
2.7% |
| Anaesthesia Procedure |
1.8% |
| Fluid Replacement |
1.8% |
| Hypotonia |
1.8% |
| Maintenance Of Anaesthesia |
1.8% |
| Mean Arterial Pressure |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
|
| Neuromuscular Block Prolonged |
26.4% |
| Drug Ineffective |
9.4% |
| Anaphylactic Shock |
7.5% |
| Hyperthermia Malignant |
7.5% |
| Anaphylactic Reaction |
5.7% |
| Rash |
5.7% |
| Victim Of Homicide |
5.7% |
| Cardio-respiratory Arrest |
3.8% |
| Heart Rate Increased |
3.8% |
| Pharmaceutical Product Complaint |
3.8% |
| Procedural Complication |
3.8% |
| Cardiomyopathy |
1.9% |
| Collapse Of Lung |
1.9% |
| Drug Effect Decreased |
1.9% |
| Drug Effect Prolonged |
1.9% |
| Dyspnoea |
1.9% |
| Endotracheal Intubation Complication |
1.9% |
| Extravasation |
1.9% |
| Homicide |
1.9% |
| Hypertension |
1.9% |
|
| Secondary |
| Neuromuscular Blockade |
24.3% |
| Drug Use For Unknown Indication |
20.6% |
| Product Used For Unknown Indication |
15.9% |
| Induction Of Anaesthesia |
5.6% |
| Surgery |
4.7% |
| Cardiac Arrest |
3.7% |
| Neuromuscular Blocking Therapy |
2.8% |
| Anaesthesia |
1.9% |
| Anaesthesia Procedure |
1.9% |
| Blood Glucose Abnormal |
1.9% |
| Fluid Replacement |
1.9% |
| Hypotonia |
1.9% |
| Mean Arterial Pressure |
1.9% |
| Pyrexia |
1.9% |
| Respiration Abnormal |
1.9% |
| Sepsis |
1.9% |
| Spinal Cord Disorder |
1.9% |
| White Blood Cell Count Decreased |
1.9% |
| Colectomy |
0.9% |
| Endotracheal Intubation |
0.9% |
|
| Heart Rate Increased |
10.3% |
| Neuromuscular Block Prolonged |
10.3% |
| Rash |
10.3% |
| Product Contamination |
7.7% |
| Tachycardia |
7.7% |
| Drug Ineffective |
5.1% |
| Hyperthermia Malignant |
5.1% |
| Muscular Weakness |
5.1% |
| Pharmaceutical Product Complaint |
5.1% |
| Ventricular Fibrillation |
5.1% |
| Wrong Drug Administered |
5.1% |
| Collapse Of Lung |
2.6% |
| Electrocardiogram Qt Prolonged |
2.6% |
| Hypertension |
2.6% |
| Infusion Site Erythema |
2.6% |
| Intra-abdominal Haemorrhage |
2.6% |
| Operative Haemorrhage |
2.6% |
| Post Procedural Complication |
2.6% |
| Respiratory Rate Increased |
2.6% |
| Therapeutic Response Unexpected With Drug Substitution |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.0% |
| Drug Use For Unknown Indication |
19.6% |
| Coronary Artery Bypass |
5.9% |
| Chemotherapy |
2.4% |
| Aortic Valve Replacement |
1.9% |
| Hormone Replacement Therapy |
1.9% |
| Catheterisation Cardiac |
1.7% |
| Pain |
1.7% |
| Mucosal Inflammation |
1.6% |
| Depression |
1.3% |
| Maintenance Of Anaesthesia |
1.3% |
| Sedation |
1.3% |
| Hypertension |
1.1% |
| Anxiety |
1.0% |
| Aortic Aneurysm Repair |
1.0% |
| Diabetes Mellitus |
1.0% |
| Procedural Pain |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
| Constipation |
0.8% |
| Mitral Valve Replacement |
0.8% |
|
| Injury |
13.9% |
| Pain |
11.4% |
| Renal Failure |
8.9% |
| Vomiting |
7.6% |
| Pulmonary Embolism |
6.3% |
| Renal Failure Acute |
6.3% |
| Urinary Retention |
6.3% |
| Fear |
3.8% |
| Renal Injury |
3.8% |
| Syncope |
3.8% |
| Unevaluable Event |
3.8% |
| Ventricular Hypertrophy |
3.8% |
| Anhedonia |
2.5% |
| Anxiety |
2.5% |
| Emotional Distress |
2.5% |
| Pancreatitis Acute |
2.5% |
| Posterior Reversible Encephalopathy Syndrome |
2.5% |
| Product Contamination |
2.5% |
| Tachycardia |
2.5% |
| Unresponsive To Stimuli |
2.5% |
|
